{"schema_version":"secwatch.filing_event.v1","accession":"0000927653-25-000010","form_type":"8-K","ticker":"MCK","cik":"0000927653","company_name":"MCKESSON CORP","filed_at":"2025-02-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.851061+00:00","generated_at":"2026-05-27T03:12:38.911429+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"McKesson Q3 FY2025 revenue $95.3B (+18% YoY), adj. EPS $8.03 (+4%); raises FY adj. EPS guidance to $32.55-$32.95","bullets":["GAAP diluted EPS $6.95 vs $4.42 prior year; adjusted EPS $8.03 vs $7.74 (+4%).","Consolidated revenue $95.3B (+18%); adjusted operating profit $1,463M (+16%).","Signed definitive agreement to acquire controlling interest in PRISM Vision Holdings (retina/ophthalmology).","Closed sale of Canada-based Rexall and Well.ca retail businesses on Dec 30, 2024.","FY2025 adjusted EPS guidance raised to $32.55-$32.95 from prior $32.40-$33.00 (19-20% growth vs FY2024)."],"urls":{"canonical":"https://secwatch.observer/filing/0000927653-25-000010","json":"https://secwatch.observer/filing/0000927653-25-000010.json","markdown":"https://secwatch.observer/filing/0000927653-25-000010.md","text":"https://secwatch.observer/filing/0000927653-25-000010.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/927653/000092765325000010/0000927653-25-000010-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/927653/000092765325000010/mck-20250205.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T03:12:38.911429+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}